Experience the Impact of Valeda: Clinically Proven for Dry AMD

Explore the science of photobiomodulation (PBM) with LumiThera’s Valeda - a groundbreaking treatment offering new hope for patients with dry AMD.

How Valeda’s PBM Therapy Works

Valeda employs a specialized multi-wavelength light system, delivering blue, red, and near-infrared light directly to the retina. These wavelengths are carefully chosen to reach different layers of the eye and activate the mitochondria – the cells’ energy centers. When stimulated, mitochondria produce more adenosine triphosphate (ATP), the molecule that powers cellular activity.

This boost in ATP supports cellular repair, reduces oxidative stress, and improves retinal circulation, all of which help slow the progression of AMD. By enhancing the health and function of retinal cells, Valeda’s PBM therapy aims to protect vision and preserve central sight before significant damage occurs.

The Three Key Wavelengths in Valeda’s PBM Therapy

Valeda’s photobiomodulation (PBM) therapy uses three specific light wavelengths – blue, red, and near-infrared – each designed to support retinal health in a unique way:

Blue Light (450 nm)

Blue light reaches the outer layers of the retina, focusing on the photoreceptor cells. It helps reduce oxidative stress, a major contributor to dry AMD, slowing retinal cell degeneration and helping protect your vision from further decline.

Red Light (660 nm)

Red light penetrates deeper into the retina, targeting the mitochondria within photoreceptors and the retinal pigment epithelium (RPE). This stimulates ATP production, providing the energy cells need for repair and rejuvenation, helping maintain retinal function and preventing additional damage from AMD.

Near-Infrared Light (850 nm)

Near-infrared light reaches the deepest retinal layers, enhancing blood flow and reducing inflammation. Improved circulation delivers nutrients and oxygen to retinal cells, while reduced inflammation helps minimize further damage, supporting overall retinal health.

By working at different depths of the retina, these three wavelengths collectively support cellular repair, improve circulation, and reduce oxidative stress and inflammation – key factors in slowing the progression of dry AMD.

By targeting the retina at different depths, these wavelengths work together to support cellular health, improve circulation, and reduce oxidative stress and inflammation—key factors that contribute to the development and progression of dry AMD.

Cellular Benefits of Photobiomodulation in AMD Treatment

Valeda’s PBM therapy works at the cellular level by enhancing mitochondrial function. Mitochondria, often called the “powerhouses” of cells, are crucial for producing energy, and their decline is closely linked to AMD. As retinal cells struggle to generate enough energy over time, cell health deteriorates, leading to vision loss. PBM helps restore mitochondrial efficiency, keeping retinal cells healthier for longer.

Here’s how PBM benefits the cells in your retina:

Increased ATP Production

Valeda’s light therapy stimulates mitochondria to produce more ATP, the energy molecule that powers cellular processes. This energy boost allows retinal cells to repair and maintain themselves more effectively, slowing the progression of dry AMD.

Reduced Oxidative Stress

Oxidative stress occurs when damaging free radicals outnumber protective antioxidants. PBM helps restore this balance, reducing cellular damage—a key factor in AMD development.

Improved Blood Flow

PBM enhances circulation within the retina, delivering essential nutrients and oxygen while removing waste products. This nourishment helps retinal cells stay healthy and resilient.

Decreased Inflammation

Inflammation accelerates retinal damage in AMD. PBM therapy reduces inflammation, creating a healthier environment for retinal cells and supporting long-term visual function.

This combination of effects addresses the root causes of dry AMD, helping to protect and preserve vision naturally.

Is Valeda PBM Therapy Right for You?

If you’ve been diagnosed with early dry AMD, Valeda’s photobiomodulation therapy offers a proactive way to protect your vision. Clinically proven, this treatment targets the underlying cellular processes that contribute to AMD, helping to slow progression before significant vision loss occurs.

Using non-invasive, painless light therapy, Valeda stimulates retinal cell repair, enhances energy production, and improves overall retinal function. By combining blue, red, and near-infrared light, Valeda provides a comprehensive approach to supporting eye health, helping you preserve your sight and maintain your quality of life.